oxycodone has been researched along with Coxarthrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, MT; Fidelholtz, J; Smith, MD; Spierings, ELH; West, CR; Wolfram, G | 1 |
| Etropolski, M; Flügel, M; Häufel, T; Kuperwasser, B; Lange, B; Laschewski, F; Rauschkolb, C | 1 |
| Hale, M; Lange, C; Okamoto, A; Rauschkolb, C; Upmalis, D | 1 |
| Hartrick, C; Oh, C; Stegmann, JU; Upmalis, D; Van Hove, I | 1 |
| Buitendyk, M; Codding, C; Marshall, DA; Pericak, D; Strauss, ME; Torrance, GW | 1 |
| Basskin, L | 1 |
1 review(s) available for oxycodone and Coxarthrosis
| Article | Year |
|---|---|
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain Management; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Tapentadol; Treatment Outcome | 2014 |
4 trial(s) available for oxycodone and Coxarthrosis
| Article | Year |
|---|---|
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcotics; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2013 |
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Double-Blind Method; Drug Administration Schedule; Drug Compounding; Female; Humans; Low Back Pain; Male; Middle Aged; Models, Biological; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol; Time Factors; Treatment Outcome | 2009 |
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled
Topics: Adult; Aged; Analgesics, Opioid; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol; Vomiting; Young Adult | 2009 |
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
Topics: Acetaminophen; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; United States | 2006 |
1 other study(ies) available for oxycodone and Coxarthrosis
| Article | Year |
|---|---|
Comparison of a scheduled narcotic for chronic pain with a similar medication for breakthrough pain only is not a clinically relevant comparison.
Topics: Acetaminophen; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |